Clinical Trials Directory

Trials / Unknown

UnknownNCT05619666

Acute Rehabilitation in Patients With COVID-19 Pneumonia

Acute Rehabilitation in Patients With COVID-19 Pneumonia a Single Center Experience From a Developing Country

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Institut za Rehabilitaciju Sokobanjska Beograd · Academic / Other
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Not accepted

Summary

COVID-19 can have different clinical manifestations including myalgia, arthralgia, neurological, cardiac, psychological and other manifestations.These patients are at greater risk of developing consequences of prolonged bed rest. Therefore physical medicine and rehabilitation could have an important role in the multidisciplinary treatment of these issues. Early respiratory and neuromuscular rehabilitation is necessary to improve functional physical limitations, performance, muscle strength, endurance as well as cognitive and emotional domains. Some studies proposed that rehabilitation protocols in the inpatient setting include early mobilisation, strength and endurance training with the aim of reducing weakness and dependency. This Study aimed to detect the effects of rehabilitation in patients with Covid-19 who were admitted in temporary Covid hospital in Serbia. Furthermore, to emphasize the importance of functional assessment of the patients, in identifying their problems and selections of priorities in planning the best therapeutic protocol.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcute rehabilitation programPatients included in the study started the rehabilitation program when they were hemodynamic stable, when it was determined that it was safe for patients. Until discharge from the hospital, a re-evaluation of neuromuscular and respiratory function was performed.

Timeline

Start date
2021-09-01
Primary completion
2022-12-01
Completion
2023-01-01
First posted
2022-11-17
Last updated
2022-11-17

Locations

2 sites across 1 country: Serbia

Source: ClinicalTrials.gov record NCT05619666. Inclusion in this directory is not an endorsement.